NASDAQ: PRPH - ProPhase Labs, Inc.

छह महीने के लिए लाभप्रदता: -87.77%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम ProPhase Labs, Inc.


कंपनी के बारे में ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the development and commercialization of novel drugs, dietary supplements, and compounds in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It provides a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.

अधिक जानकारी
The company also offers contract manufacturing services, such as consumer product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, it is involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

IPO date 1997-01-16
ISIN US74345W1080
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 0.3
Сайт https://www.prophaselabs.com
Цена ао 0.48
प्रति दिन मूल्य परिवर्तन: -3.45% (0.3015)
प्रति सप्ताह मूल्य परिवर्तन: +16.44% (0.25)
प्रति माह मूल्य परिवर्तन: -25.85% (0.3926)
3 महीने में कीमत में बदलाव: -51.92% (0.6055)
छह महीने में कीमत में बदलाव: -87.77% (2.38)
प्रति वर्ष मूल्य परिवर्तन: -95.27% (6.155)
3 वर्षों में मूल्य परिवर्तन: -96.41% (8.1)
5 वर्षों में मूल्य परिवर्तन: -86.14% (2.1)
वर्ष की शुरुआत से मूल्य परिवर्तन: -54.06% (0.6336)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 1.8 8
P/BV 1.62 8
P/E 9.69 9
EV/EBITDA -6.64 0
कुल: 7.75

क्षमता

नाम अर्थ श्रेणी
ROA, % -18.26 0
ROE, % -33.98 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0.7 7
कुल: 3.43

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.875 10
कुल: 9.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 348.32 10
लाभप्रदता Ebitda, % 429.54 10
लाभप्रदता EPS, % 274.4 10
कुल: 10

संस्थानों आयतन शेयर करना, %
Vanguard Group Inc 609347 3.38
Renaissance Technologies, LLC 245710 1.36
HighTower Advisors, LLC 173124 0.96
Geode Capital Management, LLC 137409 0.76
Perritt Capital Management, Inc. 85900 0.48
Blackrock Inc. 60754 0.34
SVB Wealth LLC 47665 0.26
Northern Trust Corporation 45962 0.25
Bank Of New York Mellon Corporation 42531 0.24
State Street Corporation 40163 0.22



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Ted William Karkus Chairman & CEO 902.2k 1959 (66 साल)
Mr. Sergio Miralles Executive VP & Chief Information Officer N/A
Mr. Kamal Obbad Senior VP and Director of Sales & Marketing - Nebula Genomics N/A
Mr. Jason Karkus President of Nebula Genomics N/A
Mr. Jed A. Latkin Chief Operating Officer & Head of Finance Department N/A 1974 (51 वर्ष)
Mr. Lance Bisesar Corporate Controller

पता: United States, Garden City. NY, 711 Stewart Avenue - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.prophaselabs.com